Immuneering
IMRX
#7469
Rank
S$0.54 B
Marketcap
S$8.38
Share price
5.28%
Change (1 day)
187.77%
Change (1 year)

Revenue for Immuneering (IMRX)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Immuneering from 2020 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A
2023 N/A-100%
2022 S$0.42 M-84.89%
2021 S$2.81 M-8.05%
2020 S$3.05 M